1225 related articles for article (PubMed ID: 18583169)
1. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity.
Saiz A; Arpa J; Sagasta A; Casamitjana R; Zarranz JJ; Tolosa E; Graus F
Neurology; 1997 Oct; 49(4):1026-30. PubMed ID: 9339684
[TBL] [Abstract][Full Text] [Related]
4. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.
Honnorat J; Saiz A; Giometto B; Vincent A; Brieva L; de Andres C; Maestre J; Fabien N; Vighetto A; Casamitjana R; Thivolet C; Tavolato B; Antoine J; Trouillas P; Graus F
Arch Neurol; 2001 Feb; 58(2):225-30. PubMed ID: 11176960
[TBL] [Abstract][Full Text] [Related]
5. Clinico-pathological findings in a patient with progressive cerebellar ataxia, autoimmune polyendocrine syndrome, hepatocellular carcinoma and anti-GAD autoantibodies.
Piccolo G; Tavazzi E; Cavallaro T; Romani A; Scelsi R; Martino G
J Neurol Sci; 2010 Mar; 290(1-2):148-9. PubMed ID: 20056249
[TBL] [Abstract][Full Text] [Related]
6. [Steroid treatment in four cases of anti-GAD cerebellar ataxia].
Bonnan M; Cabre P; Olindo S; Signate A; Saint-Vil M; Smadja D
Rev Neurol (Paris); 2008 May; 164(5):427-33. PubMed ID: 18555874
[TBL] [Abstract][Full Text] [Related]
7. [A new case of cerebellar ataxia with anti-GAD antibodies treated with corticosteroids and initially seronegative].
Birand B; Cabre P; Bonnan M; Olindo S; Smadja D
Rev Med Interne; 2006 Aug; 27(8):616-9. PubMed ID: 16797794
[TBL] [Abstract][Full Text] [Related]
8. Anti-GAD antibodies and periodic alternating nystagmus.
Tilikete C; Vighetto A; Trouillas P; Honnorat J
Arch Neurol; 2005 Aug; 62(8):1300-3. PubMed ID: 16087772
[TBL] [Abstract][Full Text] [Related]
9. Glutamic acid decarboxylase autoantibodies and neurological disorders.
Vianello M; Tavolato B; Giometto B
Neurol Sci; 2002 Oct; 23(4):145-51. PubMed ID: 12536283
[TBL] [Abstract][Full Text] [Related]
10. Opsoclonus-myoclonus-ataxia syndrome with autoantibodies to glutamic acid decarboxylase.
Markakis I; Alexiou E; Xifaras M; Gekas G; Rombos A
Clin Neurol Neurosurg; 2008 Jun; 110(6):619-21. PubMed ID: 18433986
[TBL] [Abstract][Full Text] [Related]
11. Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases.
Manto MU; Laute MA; Aguera M; Rogemond V; Pandolfo M; Honnorat J
Ann Neurol; 2007 Jun; 61(6):544-51. PubMed ID: 17600364
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous downbeat nystagmus as a clue for the diagnosis of ataxia associated with anti-GAD antibodies.
Vale TC; Pedroso JL; Alquéres RA; Dutra LA; Barsottini OG
J Neurol Sci; 2015 Dec; 359(1-2):21-3. PubMed ID: 26671081
[TBL] [Abstract][Full Text] [Related]
13. Screening for associated autoimmunity in children and adolescents with type 1 diabetes mellitus (T1DM).
Karavanaki K; Kakleas K; Paschali E; Kefalas N; Konstantopoulos I; Petrou V; Kanariou M; Karayianni C
Horm Res; 2009; 71(4):201-6. PubMed ID: 19258711
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic usefulness of glutamic acid decarboxylase antibodies in stiff-man syndrome].
Saiz A; Arias M; Fernández-Barreiro A; Mínguez A; Casamitjana R; Tolosa E; Graus F
Med Clin (Barc); 1998 Mar; 110(10):378-81. PubMed ID: 9567281
[TBL] [Abstract][Full Text] [Related]
15. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
Reinsch B; Zimmy S; Schatz H; Pfohl M
Med Klin (Munich); 2003 Feb; 98(2):67-71. PubMed ID: 12601530
[TBL] [Abstract][Full Text] [Related]
16. Stiff-person syndrome associated with cerebellar ataxia and high glutamic acid decarboxylase antibody titer.
Kono S; Miyajima H; Sugimoto M; Suzuki Y; Takahashi Y; Hishida A
Intern Med; 2001 Sep; 40(9):968-71. PubMed ID: 11579968
[TBL] [Abstract][Full Text] [Related]
17. High Titer of Circulating Antiglutamic Acid Decarboxylase Antibodies in a Patient with Cerebellar Ataxia and Type 1 Diabetes.
Kataria R; Fernandes S; Lebastchi J; Bravo CA; Sena KN
Conn Med; 2017 Mar; 81(3):161-164. PubMed ID: 29772159
[TBL] [Abstract][Full Text] [Related]
18. [Islet beta cell function in latent autoimmune diabetes in adults with islet cell antibodies].
Yang L; Zhou ZG; Huang G; Yan X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):309-14. PubMed ID: 16136967
[TBL] [Abstract][Full Text] [Related]
19. [Autoantibodies associated with autoimmune-mediated cerebellar ataxia].
Mitoma H; Nanri K
Brain Nerve; 2013 Apr; 65(4):355-64. PubMed ID: 23568983
[TBL] [Abstract][Full Text] [Related]
20. [Stiff-man syndrome. Presentation of a new case].
Fernández-Barreiro A; Villaverde R; Salmerón P; Morales A; Martínez-García FA; Meca JE; Tortosa D
Rev Neurol; 1997 Jul; 25(143):1084-7. PubMed ID: 9280641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
